Are the Independent Actually Dependent? Is Cochrane’s Ivermectin Analysis Biased?

Are the Independent Actually Dependent Is Cochrane’s Ivermectin Analysis Biased

Cochrane has developed a brand as a prestigious, independent and unbiased medical research non-profit pursuing evidence-based choices involving healthy interventions of health professionals, patients, and policy makers. With 53 review groups based at research institutes around the globe, the well-respected organization includes 30,000 volunteer experts. Long a reliable player in this field of evidence-based medicine, it was some activity in the German-speaking world that prompted TrialSite’s attention recently. Recently, Cochrane Austria opted to evaluate ivermectin in a document titled “Ivermectin against corona: probably ineffective.” Now an organization that prides itself on objective, unbiased and systematic reviews might look more carefully at the over 50 clinical trials that demonstrate positive outcomes. There is a growing list of dedicated, committed biomedical researchers that have made a case via meta-analyses that ivermectin should be considered for some form of emergency use authorization. For example, medical evidence expert Dr. Tess Lawrie, not on any industry payroll, has performed a comprehensive meta-analysis showcasing what she and many others argue is compelling...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee